Cormorant Asset Management »

Abivax SA F shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $166M 2.0M 84.90
2025-06-30 $16M 2.1M 7.65
2025-03-31 $13M 2.1M 6.25
2024-12-31 $16M 2.1M 7.32
2024-09-30 $25M 2.1M 11.52
2024-06-30 $28M 2.1M 13.22
2024-03-31 $31M 2.1M 14.30
2023-12-31 $23M 2.1M 10.70

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F